140 related articles for article (PubMed ID: 10766293)
1. The rôle of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective.
Cole C; Foster AJ; Freeman S; Jaffar M; Murray PE; Strafford IJ
Anticancer Drug Des; 1999 Oct; 14(5):383-92. PubMed ID: 10766293
[TBL] [Abstract][Full Text] [Related]
2. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase: a two-face Janus in anticancer chemotherapy.
Focher F; Spadari S
Curr Cancer Drug Targets; 2001 Aug; 1(2):141-53. PubMed ID: 12188887
[TBL] [Abstract][Full Text] [Related]
4. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
5. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
[TBL] [Abstract][Full Text] [Related]
6. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.
Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T
Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429
[TBL] [Abstract][Full Text] [Related]
7. Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro.
Igawa H; Fujieda S; Kimura Y; Sugimoto C; Tanaka N; Ohtsubo T; Kato Y; Saito H
Oncol Rep; 2003; 10(4):967-71. PubMed ID: 12792754
[TBL] [Abstract][Full Text] [Related]
8. [Thymidine phosphorylase and angiogenesis].
Akiyama S
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1208-11. PubMed ID: 10945018
[TBL] [Abstract][Full Text] [Related]
9. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis.
Stevenson DP; Milligan SR; Collins WP
Am J Pathol; 1998 Jun; 152(6):1641-6. PubMed ID: 9626068
[TBL] [Abstract][Full Text] [Related]
10. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast.
Ellis PE; Wong Te Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perret CW
Anticancer Res; 2002; 22(2A):857-61. PubMed ID: 12014662
[TBL] [Abstract][Full Text] [Related]
11. Regulation of expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colon carcinoma cells.
Schwartz EL; Wan E; Wang FS; Baptiste N
Cancer Res; 1998 Apr; 58(7):1551-7. PubMed ID: 9537263
[TBL] [Abstract][Full Text] [Related]
12. Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer.
Bera H; Chigurupati S
Eur J Med Chem; 2016 Nov; 124():992-1003. PubMed ID: 27783978
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
Griffiths L; Stratford IJ
Br J Cancer; 1997; 76(6):689-93. PubMed ID: 9310231
[TBL] [Abstract][Full Text] [Related]
14. Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo.
Makower D; Wadler S; Haynes H; Schwartz EL
Clin Cancer Res; 1997 Jun; 3(6):923-9. PubMed ID: 9815767
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds.
Liekens S; Balzarini J; Hernández AI; De Clercq E; Priego EM; Camarasa MJ; Pérez-Pérez MJ
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):975-80. PubMed ID: 17065049
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived endothelial cell growth factor.
Heldin CH; Usuki K; Miyazono K
J Cell Biochem; 1991 Nov; 47(3):208-10. PubMed ID: 1724243
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
[TBL] [Abstract][Full Text] [Related]
18. Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.
Stevenson DP; Collins WP; Farzaneh F; Hata K; Miyazaki K
Am J Pathol; 1998 Nov; 153(5):1573-8. PubMed ID: 9811349
[TBL] [Abstract][Full Text] [Related]
19. [Enhancement effect of interferon gamma on the sensitivity of RT4 bladder cancer cells to 5'-deoxy-5-fluorouridine,and 5-fluorouracil through up-regulation of PD-ECGF/TP].
Li G; Yan CY; Wen DG; Ding Q; Zhang YF
Ai Zheng; 2004 Aug; 23(8):929-32. PubMed ID: 15301717
[TBL] [Abstract][Full Text] [Related]
20. Role of thymidine phosphorylase in biomodulation of fluoropyrimidines.
Morita T; Matsuzaki A; Suzuki K; Tokue A
Curr Pharm Biotechnol; 2001 Sep; 2(3):257-67. PubMed ID: 11530879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]